These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37052239)

  • 1. Tilianin alleviates lipid deposition and fibrosis in mice with nonalcoholic steatohepatitis by activating the PPARα/Nnat axis.
    Ke F; Wu X; Zheng J; Li C
    Drug Dev Res; 2023 Aug; 84(5):922-936. PubMed ID: 37052239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
    Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
    Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
    Ren T; Zhu J; Zhu L; Cheng M
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity.
    Wu H; Lou T; Pan M; Wei Z; Yang X; Liu L; Feng M; Shi L; Qu B; Cong S; Chen K; Yang H; Liu J; Li Y; Jia Z; Xiao H
    J Ethnopharmacol; 2024 May; 326():117841. PubMed ID: 38310988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway.
    Xie Y; Jin Y; Wen J; Li G; Huai X; Duan Y; Ni F; Fu J; Li M; Li L; Yan M; Cao L; Xiao W; Yang H; Wang ZZ
    Biomed Pharmacother; 2024 Jul; 176():116908. PubMed ID: 38850668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway.
    Deng YF; Xu QQ; Chen TQ; Ming JX; Wang YF; Mao LN; Zhou JJ; Sun WG; Zhou Q; Ren H; Zhang YH
    Phytomedicine; 2022 Sep; 104():154241. PubMed ID: 35749827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe
    Hua YQ; Zeng Y; Xu J; Xu XL
    Phytomedicine; 2021 Jan; 81():153412. PubMed ID: 33234364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of curcumol on liver function and fibrosis in rats of nonalcoholic fatty liver disease and its mechanism].
    Qi SY; Huang H; Li YK; Pei LG; Zhang WJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):611-615. PubMed ID: 34821093
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
    Ni XX; Li XY; Wang Q; Hua J
    J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and mechanism of action of Yanxiao Di'naer formula for non-alcoholic steatohepatitis treatment based on metabolomics and RNA sequencing.
    Zheng DX; Hou Q; Xue TT; Gao X; Geng RY; Wen LM; Wang Z; Yin Q; Yin HL; Hu JP; Yang JH
    J Ethnopharmacol; 2024 Oct; 333():118487. PubMed ID: 38925322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
    Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
    Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
    Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways.
    Lee SM; Koh DH; Jun DW; Roh YJ; Kang HT; Oh JH; Kim HS
    Clin Mol Hepatol; 2022 Oct; 28(4):827-840. PubMed ID: 35730208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice.
    Wei J; Shi M; Wu WQ; Xu H; Wang T; Wang N; Ma JL; Wang YG
    World J Gastroenterol; 2011 Dec; 17(47):5203-13. PubMed ID: 22215946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
    Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
    Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model.
    Aoyama Y; Naiki-Ito A; Xiaochen K; Komura M; Kato H; Nagayasu Y; Inaguma S; Tsuda H; Tomita M; Matsuo Y; Takiguchi S; Takahashi S
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis.
    Ran S; Song L; Yang H; Yu J; Zhen Y; Liu Q
    PLoS One; 2024; 19(3):e0301133. PubMed ID: 38547097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rg5 inhibits lipid accumulation and hepatocyte apoptosis via the Notch1 signaling pathway in NASH mice.
    Li N; Zhu C; Fu R; Ma X; Duan Z; Fan D
    Phytomedicine; 2024 Feb; 124():155287. PubMed ID: 38176268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.